Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A12316 | 30517626 | Endocrinology | Hepatic HKDC1 Expression Contributes to Liver Metabolism. | 2019 | Details |
| A12317 | 30516845 | Hepatology | Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis. | 2019 | Details |
| A12318 | 30516830 | Hepatology | Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages. | 2019 | Details |
| A12319 | 30516570 | Eur J Gastroenterol Hepatol | The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis. | 2019 | Details |
| A12320 | 30516498 | Georgian Med News | EFFECTIVENESS OF NONALCOHOLIC STEATOHEPATITIS CORRECTION ON THE BAСKGROUND OF OBESITY WITH CONCOMITANT CHRONIC KIDNEY DISEASE. | 2018 | Details |
| A12321 | 30516003 | Physiol Rep | Exercise training suppresses scavenger receptor CD36 expression in kupffer cells of nonalcoholic steatohepatitis model mice. | 2018 | Details |
| A12323 | 30515676 | Hepatol Int | Precision-cut liver slices: a versatile tool to advance liver research. | 2018 | Details |
| A12324 | 30515622 | Obes Surg | Improvement in Non-alcoholic Fatty Liver Disease Score Correlates with Weight Loss in Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: a Two-Centre Study from an Asian Cohort. | 2019 | Details |
| A12325 | 30515538 | Anal Bioanal Chem | Mapping the triglyceride distribution in NAFLD human liver by MALDI imaging mass spectrometry reveals molecular differences in micro and macro steatosis. | 2018 | Details |
| A12326 | 30515395 | Biomed Res Int | Oxidative Stress and Nonalcoholic Fatty Liver Disease in Hemodialysis Patients. | 2018 | Details |
| A12327 | 30515333 | Int J Hepatol | Relationship between Experimental Diet in Rats and Nonalcoholic Hepatic Disease: Review of Literature. | 2018 | Details |
| A12328 | 30514673 | Nan Fang Yi Ke Da Xue Xue Bao | [Effects of sera of rats fed with Huganqingzhi tablets on endoplasmic reticulum stress in a HepG2 cell model of nonalcoholic fatty liver disease]. | 2018 | Details |
| A12329 | 30513881 | Nutrients | Apple Pomace Consumption Favorably Alters Hepatic Lipid Metabolism in Young Female Sprague-Dawley Rats Fed a Western Diet. | 2018 | Details |
| A12330 | 30512987 | Am J Physiol Endocrinol Metab | Estrogen receptor-α signaling maintains immunometabolic function in males and is obligatory for exercise-induced amelioration of nonalcoholic fatty liver. | 2018 | Details |
| A12331 | 30511955 | J Musculoskelet Neuronal Interact | Can obesity-induced inflammation in skeletal muscle and intramuscular adipose tissue accurately detect liver fibrosis? | 2018 | Details |
| A12332 | 30511198 | Dig Dis Sci | Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A12333 | 30511049 | J Clin Gastroenterol Hepatol | A Comparison of the Liver Fat Score and CT Liver-to-Spleen Ratio as Predictors of Fatty Liver Disease by HIV Serostatus. | 2018 | Details |
| A12334 | 30510994 | Cell Mol Gastroenterol Hepatol | Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice. | 2018 | Details |
| A12335 | 30510243 | Exp Mol Med | Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression. | 2018 | Details |
| A12336 | 30509561 | J Formos Med Assoc | Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease. | 2018 | Details |
| A12337 | 30509175 | BMC Genomics | Corn dried distillers grains with solubles (cDDGS) in the diet of pigs change the expression of adipose genes that are potential therapeutic targets in metabolic and cardiovascular diseases. | 2018 | Details |
| A12339 | 30500887 | Endocr Rev | Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12340 | 30500848 | PLoS One | Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease. | 2018 | Details |
| A12341 | 30500173 | Anal Chem | LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics. | 2018 | Details |
| A12343 | 30499266 | J Biomed Opt | Diffuse reflectance spectroscopy accurately discriminates early and advanced grades of fatty liver in mice. | 2018 | Details |
| A12344 | 30498904 | J Gastroenterol | A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update. | 2018 | Details |
| A12346 | 30498712 | Hepatobiliary Surg Nutr | New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver disease. | 2018 | Details |
| A12347 | 30498378 | Hepat Med | Universal Index for Cirrhosis (UIC index): The development and validation of a novel index to predict advanced liver disease. | 2018 | Details |
| A12348 | 30496690 | Postgrad Med | Clinical workup of fatty liver for the primary care provider. | 2018 | Details |
| A12349 | 30496542 | J Clin Endocrinol Metab | Sex Hormone-Binding Globulin Expression Correlates With Acetyl-Coenzyme A Carboxylase and Triglyceride Content in Human Liver. | 2019 | Details |
| A12350 | 30495974 | Am J Physiol Gastrointest Liver Physiol | Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trials. | 2018 | Details |
| A12351 | 30489192 | J Med Food | Hovenia dulcis Extract Attenuates High-Fat Diet-Induced Hepatic Lipid Accumulation and Hypertriglyceridemia in C57BL/6 Mice. | 2018 | Details |
| A12356 | 30488259 | Obes Surg | A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy. | 2019 | Details |
| A12357 | 30488108 | Eur Radiol | Magnitude dependent discordance in liver stiffness measurements using elastography point quantification with transient elastography as the reference test. | 2018 | Details |
| A12358 | 30487694 | World J Gastroenterol | Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables. | 2018 | Details |
| A12359 | 30487357 | Exp Anim | AIM-deficient mouse fed a high-trans fat, high-cholesterol diet: a new animal model for nonalcoholic fatty liver disease. | 2018 | Details |
| A12360 | 30487332 | Clin Calcium | [Secondary osteoporosis. Bone disease in liver cirrhosis.] | 2019 | Details |
| A12361 | 30486798 | BMC Gastroenterol | Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study. | 2018 | Details |
| A12362 | 30484323 | Antioxid Redox Signal | Isosteviol Protects Free Fatty Acid- and High Fat Diet-Induced Hepatic Injury via Modulating PKC-β/p66Shc/ROS and Endoplasmic Reticulum Stress Pathways. | 2019 | Details |
| A12363 | 30484310 | J Agric Food Chem | Folic Acid Reduced Triglycerides Deposition in Primary Chicken Hepatocytes. | 2018 | Details |
| A12364 | 30483909 | Dig Dis Sci | Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China. | 2018 | Details |
| A12365 | 30483596 | JGH Open | Kombiglyze (metformin and saxagliptin)-induced hepatotoxicity in a patient with non-alcoholic fatty liver disease. | 2018 | Details |
| A12366 | 30483595 | JGH Open | Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications. | 2018 | Details |
| A12367 | 30483565 | JGH Open | Is non-alcoholic fatty liver disease a reflection of what we eat or simply how much we eat? | 2018 | Details |
| A12368 | 30483564 | JGH Open | Non-alcoholic fatty liver disease in patients with autoimmune hepatitis. | 2018 | Details |
| A12369 | 30483562 | JGH Open | Prevalence and risk factors of non-alcoholic fatty liver disease in Bangladesh. | 2018 | Details |
| A12370 | 30483546 | JGH Open | Serum ferritin as a non-invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A12371 | 30483536 | JGH Open | Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial. | 2017 | Details |
| A12372 | 30483219 | Front Endocrinol (Lausanne) | Comparison of the Prevalence of Metabolic Disease Between Two Types of Urbanization in China. | 2018 | Details |
| A12373 | 30482910 | Nat Rev Gastroenterol Hepatol | The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2019 | Details |
| A12374 | 30482436 | J Pharmacol Sci | Lipid-modulate activity of Cichorium glandulosum Boiss. et Huet polysaccharide in nonalcoholic fatty liver disease larval zebrafish model. | 2018 | Details |
| A12375 | 30481883 | Zhonghua Gan Zang Bing Za Zhi | [Predictive value of serum glycosylated hemoglobin for the onset of nonalcoholic fatty liver disease]. | 2018 | Details |
| A12376 | 30481403 | IUBMB Life | IL-17A-mediated ERK1/2/p65 signaling pathway is associated with cell apoptosis after non-alcoholic steatohepatitis. | 2018 | Details |
| A12377 | 30479664 | Therap Adv Gastroenterol | Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis. | 2018 | Details |
| A12378 | 30477827 | Complement Ther Med | The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial. | 2018 | Details |
| A12379 | 30477455 | BMC Endocr Disord | Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial. | 2018 | Details |
| A12381 | 30476585 | Clin Gastroenterol Hepatol | Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease. | 2018 | Details |
| A12382 | 30476583 | Clin Gastroenterol Hepatol | Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study. | 2018 | Details |
| A12383 | 30474798 | J Endocrinol Invest | Periostin concentrations in childhood-onset craniopharyngioma patients. | 2018 | Details |
| A12384 | 30474288 | Obes Rev | Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity? | 2018 | Details |
| A12385 | 30474191 | Diabet Med | Utility of HbA1c assessment in people with diabetes awaiting liver transplantation. | 2019 | Details |
| A12386 | 30473540 | Biosci Rep | Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease. | 2018 | Details |
| A12387 | 30473486 | Mol Metab | Tannic acid, a novel histone acetyltransferase inhibitor, prevents non-alcoholic fatty liver disease both in vivo and in vitro model. | 2018 | Details |
| A12389 | 30473364 | Lancet | Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK. | 2018 | Details |
| A12390 | 30473057 | Metabolism | Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models. | 2018 | Details |
| A12391 | 30473026 | Life Sci | p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease. | 2018 | Details |
| A12392 | 30472977 | J Pharm Pharm Sci | Non-alcoholic Steatohepatitis (NASH) Drug Discovery - Building a Consensus on ADME Screening Tools and Clinical Pharmacology Strategies to Aid Candidate Development. | 2018 | Details |
| A12394 | 30472795 | Mass Spectrom Rev | Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches. | 2018 | Details |
| A12397 | 30472683 | Gut | Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study. | 2018 | Details |
| A12398 | 30472196 | Diabetes Metab | Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes. | 2018 | Details |
| A12399 | 30471458 | Clin Gastroenterol Hepatol | Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12400 | 30470953 | Dig Dis Sci | NAFLD Induction Delays Postoperative Liver Regeneration of ALPPS in Rats. | 2018 | Details |
| A12401 | 30470912 | Diabetologia | Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. | 2018 | Details |
| A12402 | 30470823 | Oncogene | Indian Hedgehog links obesity to development of hepatocellular carcinoma. | 2018 | Details |
| A12403 | 30469392 | J Clin Med | Bidirectional Association between Nonalcoholic Fatty Liver Disease and Gallstone Disease: A Cohort Study. | 2018 | Details |
| A12404 | 30469339 | Nutrients | Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD. | 2018 | Details |
| A12405 | 30469030 | Redox Biol | Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. | 2018 | Details |
| A12406 | 30468651 | Front Biosci (Landmark Ed) | Fructose at the crossroads of the metabolic syndrome and obesity epidemics. | 2019 | Details |
| A12407 | 30467936 | Pediatr Diabetes | Non-alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjects. | 2018 | Details |
| A12408 | 30467685 | Hormones (Athens) | Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment. | 2018 | Details |
| A12409 | 30467325 | Sci Rep | BET Inhibition Improves NASH and Liver Fibrosis. | 2018 | Details |
| A12410 | 30466956 | Clin Nutr | Lean non-alcoholic fatty liver disease. | 2018 | Details |
| A12411 | 30466676 | Med Clin North Am | The Future of Nonalcoholic Fatty Liver Disease Treatment. | 2018 | Details |
| A12412 | 30466110 | Cell Physiol Biochem | ATP Citrate Lyase and LncRNA NONMMUT010685 Play Crucial Role in Nonalcoholic Fatty Liver Disease Based on Analysis of Microarray Data. | 2018 | Details |
| A12413 | 30465867 | Magn Reson Imaging | Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis. | 2018 | Details |
| A12414 | 30465824 | Free Radic Biol Med | Prolonged PM2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia. | 2018 | Details |
| A12417 | 30463916 | Sci Transl Med | Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis. | 2018 | Details |
| A12418 | 30462873 | NMR Biomed | Mapping tissue water T1 in the liver using the MOLLI T1 method in the presence of fat, iron and B0 inhomogeneity. | 2018 | Details |
| A12419 | 30462610 | Horm Mol Biol Clin Investig | The impact of steatosis on liver regeneration. | 2018 | Details |
| A12420 | 30461221 | J Diabetes Investig | Effects of canagliflozin on body composition and hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A12421 | 30460863 | Pharm Biol | Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus. | 2018 | Details |
| A12422 | 30460699 | Lipids | Unsaturated Fatty Acids Increase the Expression of Hepassocin through a Signal Transducer and Activator of Transcription 3-Dependent Pathway in HepG2 Cells. | 2018 | Details |
| A12423 | 30459715 | Front Endocrinol (Lausanne) | Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD. | 2018 | Details |
| A12424 | 30459251 | Diabetes | Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis. | 2018 | Details |
| A12425 | 30458883 | J Transl Med | Matrine attenuates endoplasmic reticulum stress and mitochondrion dysfunction in nonalcoholic fatty liver disease by regulating SERCA pathway. | 2018 | Details |
| A12426 | 30458848 | Lipids Health Dis | A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease. | 2018 | Details |
| A12427 | 33266617 | Entropy (Basel) | Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome. | 2018 | Details |
| A12428 | 30458247 | Clin Gastroenterol Hepatol | Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States. | 2018 | Details |
| A12429 | 30458246 | Clin Gastroenterol Hepatol | Population-Based Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults With Type 2 Diabetes. | 2018 | Details |
| A12430 | 30458048 | PLoS One | One-year weight management lowers lipopolysaccharide-binding protein and its implication in metainflammation and liver fibrosis. | 2018 | Details |